206 related articles for article (PubMed ID: 30181180)
1. p63-Dependent Dickkopf3 Expression Promotes Esophageal Cancer Cell Proliferation via CKAP4.
Kajiwara C; Fumoto K; Kimura H; Nojima S; Asano K; Odagiri K; Yamasaki M; Hikita H; Takehara T; Doki Y; Morii E; Kikuchi A
Cancer Res; 2018 Nov; 78(21):6107-6120. PubMed ID: 30181180
[TBL] [Abstract][Full Text] [Related]
2. Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
Shinno N; Kimura H; Sada R; Takiguchi S; Mori M; Fumoto K; Doki Y; Kikuchi A
Oncogene; 2018 Jun; 37(26):3471-3484. PubMed ID: 29563607
[TBL] [Abstract][Full Text] [Related]
3. DKK3/CKAP4 axis is associated with advanced stage and poorer prognosis in oral cancer.
Katase N; Kudo K; Ogawa K; Sakamoto Y; Nishimatsu SI; Yamauchi A; Fujita S
Oral Dis; 2023 Nov; 29(8):3193-3204. PubMed ID: 35708905
[TBL] [Abstract][Full Text] [Related]
4. CKAP4 is a Dickkopf1 receptor and is involved in tumor progression.
Kimura H; Fumoto K; Shojima K; Nojima S; Osugi Y; Tomihara H; Eguchi H; Shintani Y; Endo H; Inoue M; Doki Y; Okumura M; Morii E; Kikuchi A
J Clin Invest; 2016 Jul; 126(7):2689-705. PubMed ID: 27322059
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
6. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
7. CKAP4 is identified as a receptor for Dickkopf in cancer cells.
Bhavanasi D; Speer KF; Klein PS
J Clin Invest; 2016 Jul; 126(7):2419-21. PubMed ID: 27322056
[TBL] [Abstract][Full Text] [Related]
8. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
9. PTPLAD2 is a tumor suppressor in esophageal squamous cell carcinogenesis.
Zhu S; Wang Z; Zhang Z; Wang J; Li Y; Yao L; Mei Q; Zhang W
FEBS Lett; 2014 Mar; 588(6):981-9. PubMed ID: 24530685
[TBL] [Abstract][Full Text] [Related]
10. NKILA inhibits NF-κB signaling and suppresses tumor metastasis.
Ke S; Li RC; Meng FK; Fang MH
Aging (Albany NY); 2018 Jan; 10(1):56-71. PubMed ID: 29348395
[TBL] [Abstract][Full Text] [Related]
11. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway.
Zhang GJ; Zhao J; Jiang ML; Zhang LC
Biochem Biophys Res Commun; 2018 Feb; 496(2):387-393. PubMed ID: 29326045
[TBL] [Abstract][Full Text] [Related]
12. Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation.
Kawazoe T; Saeki H; Oki E; Oda Y; Maehara Y; Mori M; Taniguchi K
Mol Cancer Res; 2020 Dec; 18(12):1876-1888. PubMed ID: 33004621
[TBL] [Abstract][Full Text] [Related]
13. p63 regulates growth of esophageal squamous carcinoma cells via the Akt signaling pathway.
Ye S; Lee KB; Park MH; Lee JS; Kim SM
Int J Oncol; 2014 Jun; 44(6):2153-9. PubMed ID: 24718831
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
15. Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma.
Wang C; Cheng L; Song S; Wu S; Sun G
J Cell Physiol; 2020 Nov; 235(11):8224-8235. PubMed ID: 31957872
[TBL] [Abstract][Full Text] [Related]
16. Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma.
Li MY; Fan LN; Han DH; Yu Z; Ma J; Liu YX; Li PF; Zhao DH; Chai J; Jiang L; Li SL; Xiao JJ; Duan QH; Ye J; Shi M; Nie YZ; Wu KC; Liao DJ; Shi Y; Wang Y; Yan QG; Guo SP; Bian XW; Zhu F; Zhang J; Wang Z
J Clin Invest; 2020 Aug; 130(8):4301-4319. PubMed ID: 32396532
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53.
Chen Y; Xin H; Peng H; Shi Q; Li M; Yu J; Tian Y; Han X; Chen X; Zheng Y; Li J; Yang Z; Yang L; Hu J; Huang X; Liu Z; Huang X; Zhou H; Cui X; Li F
Cancer Res; 2020 Jun; 80(11):2175-2189. PubMed ID: 32066565
[TBL] [Abstract][Full Text] [Related]
18. The role of Dickkopf-3 overexpression in esophageal adenocarcinoma.
Wang Z; Lin L; Thomas DG; Nadal E; Chang AC; Beer DG; Lin J
J Thorac Cardiovasc Surg; 2015 Aug; 150(2):377-385.e2. PubMed ID: 26093488
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
[TBL] [Abstract][Full Text] [Related]
20. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
